查看購物車
  • Simplified Chinese
  • English
  • Japanese
2021-2031 年北美藥物警戒和藥物安全軟體市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1819687

2021-2031 年北美藥物警戒和藥物安全軟體市場報告（範圍、細分、動態和競爭分析）

North America Pharmacovigilance and Drug Safety Software Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 210 Pages | 訂單完成後即時交付

價格

2023 年北美藥物警戒和藥物安全軟體市場價值約為 1.0003 億美元，預計到 2031 年將成長至約 1.8272 億美元，在 2023 年至 2031 年的預測期內年複合成長率(CAGR) 為 7.8%。

藥物不良反應發生率不斷上升

藥物不良反應 (ADR) 的增加是推動北美藥物警戒和藥物安全軟體市場成長的重要因素。慢性病的盛行率不斷上升，導致處方藥數量增加，進而增加了 ADR 的可能性。鑑於所有藥物都可能引起不良反應，因此在開立處方時進行徹底的風險效益分析至關重要。 ADR 對當代醫療保健構成了巨大的挑戰，尤其是在治療方案日益複雜、人口老化以及多種慢性疾病日益流行的背景下。

藥物警戒軟體在幫助醫療保健提供者和製藥公司系統地收集、分析和報告與ADR相關的資料發揮著至關重要的作用。該軟體對於應對ADR帶來的挑戰至關重要，美國食品藥物管理局不良事件通報系統（FAERS）的資料就證明了這一點。該系統僅在2022年就報告了超過125萬例嚴重不良反應病例和超過17.5萬例死亡病例。

某些藥物（例如茶鹼與大環內酯類抗生素的相互作用以及維生素K用量增加）與不良反應（ADR）有關。隨著報告的ADR數量持續增加，製藥公司、醫療保健提供者和監管機構面臨越來越大的壓力，需要加強藥品安全監測和報告流程。藥物警戒和藥物安全軟體簡化了不良反應的檢測、評估和預防，從而加快了反應速度並提高了風險評估的準確性。因此，ADR發生率的上升是藥物警戒和藥物安全軟體市場成長的關鍵驅動力。

北美市場概況

北美藥物警戒和藥品安全軟體市場細分為美國、加拿大和墨西哥。北美被認為是最早採用藥品安全法規的地區。此外，該地區的製藥業數位化進程正在加速。據加拿大健康資訊網 (Canada Health Infoway) 稱，加拿大的製藥公司擴大採用數位醫療服務，預計這將在未來幾年推動對藥物警戒和藥品安全軟體的需求。製藥業日益成長的數位化預計將增強對有效藥品監控的需求，從而增加對藥物警戒解決方案的需求。

隨著報告的不良事件數量的增加，藥物警戒和藥物安全專業人員在準確有效地評估這些資料方面面臨更大的挑戰。先進技術的實施對於減輕這些專業人員的工作量，同時確保對不良事件資料進行精確和系統的分析至關重要。

市場區隔分析

北美藥物警戒和藥物安全軟體市場可以根據各種因素進行分類，包括產品、部署、企業規模、形式、功能、最終用戶和國家。

1. 產品：市場分為軟體和服務，其中軟體部分在 2023 年將佔據更大的佔有率。

2. 部署：市場進一步細分為基於雲端的解決方案和內部部署解決方案，其中雲端解決方案將在 2023 年佔據主導市場佔有率。

3. 企業規模：市場分為大型企業和中小型企業 (SME)，其中大型企業在 2023 年佔據相當大的佔有率。

4.表格：軟體提供標準表格和定製表格，其中標準表格在市場上較為流行。

5. 功能：市場包括訊號和風險管理、問題追蹤、案例管理、臨床安全管理、品質和合規性以及醫療保健分析等各種功能，其中訊號和風險管理將成為 2023 年最大的細分市場。

6. 最終用戶：主要最終用戶包括製藥和生物技術公司、合約研究組織和業務流程外包公司，其中製藥和生物技術公司佔據領先市場佔有率。

7. 國家：市場分為美國、加拿大和墨西哥，美國將在 2023 年佔據市場主導地位。

市場關鍵參與者

北美藥物警戒和藥物安全軟體市場活躍著多家知名公司，包括Veeva Systems Inc.、IQVIA Holdings Inc.、AB Cube SAS、ArisGlobal LLC、甲骨文公司、Max Application、ICON Plc、Cognizant Technology Solutions Corp、埃森哲公司、Syneos Health Inc.、Genpact Ltd.、LabPartory Corpc Technologies、 Holdingspine、Cakak）這些公司在開發創新解決方案以加強該地區藥物安全和藥物警戒實踐方面處於領先地位。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：
  • 假設和局限性

第4章：北美藥物警戒與藥品安全軟體市場格局

  • 概述
    • 軟體/服務提供者：
    • 系統整合商：
    • 監理機構：
    • 最終用戶：
  • 價值鏈中的供應商列表

第5章：北美藥物警戒與藥品安全軟體市場－關鍵市場動態

  • 市場促進因素
    • 藥物不良反應發生率上升
    • 藥物警戒全球化
    • 藥物開發支出激增
  • 市場限制
    • 安裝和維護成本高
  • 市場機會
    • 軟體與 AI、ML 和 NLP 的整合
  • 未來趨勢
    • 基於雲端的藥物警戒和藥物安全軟體：
  • 促進因素和限制因素的影響：

第6章：北美藥物警戒與藥品安全軟體市場 - 分析

  • 2021-2031年北美藥物警戒與藥物安全軟體市場收入
  • 北美藥物警戒與藥品安全軟體市場預測分析

第7章：北美藥物警戒和藥品安全軟體市場分析 - 按產品

  • 軟體
  • 服務

第 8 章：北美藥物警戒與藥物安全軟體市場分析 - 按部署

  • 雲
  • 本地

第9章：北美藥物警戒與藥品安全軟體市場分析－依企業規模

  • 大型企業
  • 中小企業

第 10 章：北美藥物警戒和藥品安全軟體市場分析 - 按形式

  • 標準
  • 客製化

第 11 章：北美藥物警戒和藥品安全軟體市場分析 - 按功能

  • 訊號和風險管理
  • 問題追蹤和不良事件追蹤
  • 案件管理
  • 臨床安全管理與臨床試驗安全
  • 品質與合規
  • 醫學寫作
  • 審計支援和培訓合規性
  • 醫療保健分析
  • 其他

第 12 章：北美藥物警戒和藥物安全軟體市場分析 - 按最終用戶

  • 製藥和生物技術公司
  • 合約研究組織
  • 業務流程外包（BPO）公司
  • 其他

第 13 章：北美藥物警戒與藥品安全軟體市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 14 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第15章：產業格局

  • 概述
  • 市場計劃
  • 夥伴關係與合作

第 16 章：公司簡介

  • ArisGlobal LLC
  • Max Application
  • Oracle Corp
  • Veeva Systems Inc
  • IQVIA Holdings Inc
  • ICON Plc
  • Cognizant Technology Solutions Corp
  • Accenture Plc
  • Syneos Health Inc
  • Genpact Ltd.
  • AB Cube S.A.S.
  • Laboratory Corp of America Holdings
  • Parexel International Corp
  • Qinecsa Solutions
  • Clinevo Technologies

第 17 章：附錄

Product Code: TIPRE00022774

The North American pharmacovigilance and drug safety software market was valued at approximately $100.03 million in 2023 and is projected to grow to about $182.72 million by 2031, reflecting a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2023 to 2031.

Increasing Incidence of Adverse Drug Reactions

The rise in adverse drug reactions (ADRs) is a significant factor driving the growth of the pharmacovigilance and drug safety software market in North America. The prevalence of chronic diseases is on the rise, leading to an increase in the number of medications prescribed, which in turn raises the potential for ADRs. Given that all medications can cause adverse reactions, conducting a thorough risk-benefit analysis is crucial whenever a drug is prescribed. ADRs pose a considerable challenge in contemporary healthcare, especially with the increasing complexity of treatment regimens, an aging population, and the prevalence of multiple chronic conditions.

Pharmacovigilance software plays a vital role in enabling healthcare providers and pharmaceutical companies to systematically collect, analyze, and report data related to ADRs. This software is essential for addressing the challenges posed by ADRs, as evidenced by the data from the US Food and Drug Administration's Adverse Event Reporting System (FAERS), which reported over 1.25 million severe adverse cases and more than 175,000 deaths in 2022 alone.

The interaction of certain medications, such as theophylline with macrolide antibiotics and increased vitamin K consumption, has been linked to ADRs. As the number of reported ADRs continues to rise, there is increasing pressure on pharmaceutical companies, healthcare providers, and regulatory bodies to enhance drug safety monitoring and reporting processes. Pharmacovigilance and drug safety software streamline the detection, assessment, and prevention of adverse effects, facilitating quicker response times and more accurate risk assessments. Consequently, the growing incidence of ADRs is a key driver of market growth in pharmacovigilance and drug safety software.

Overview of the North American Market

The North American pharmacovigilance and drug safety software market is segmented into the United States, Canada, and Mexico. North America is recognized as an early adopter of regulations concerning pharmaceutical and drug safety. Additionally, the region is witnessing a surge in digitization within the pharmaceutical sector. According to Canada Health Infoway, pharmaceutical companies in Canada are increasingly adopting digital health services, which is expected to drive demand for pharmacovigilance and drug safety software in the coming years. The growing digitization in the pharmaceutical industry is anticipated to enhance the need for effective monitoring of pharmaceutical drugs, thereby increasing the demand for pharmacovigilance solutions.

As the volume of reported adverse events rises, pharmacovigilance and drug safety professionals face greater challenges in accurately and efficiently evaluating this data. The implementation of advanced technologies is crucial to alleviate the workload of these professionals while ensuring precise and systematic analysis of adverse event data.

Market Segmentation Analysis

The North American pharmacovigilance and drug safety software market can be categorized based on various factors, including offering, deployment, enterprise size, form, functionality, end user, and country.

1. Offering: The market is divided into software and services, with the software segment holding a larger share in 2023.

2. Deployment: The market is further segmented into cloud-based and on-premises solutions, with cloud solutions dominating the market share in 2023.

3. Enterprise Size: The market is categorized into large enterprises and small to medium-sized enterprises (SMEs), with large enterprises holding a significant share in 2023.

4. Form: The software is available in standard and customized forms, with the standard form being more prevalent in the market.

5. Functionality: The market includes various functionalities such as signal and risk management, issue tracking, case management, clinical safety management, quality and compliance, and healthcare analytics, with signal and risk management being the largest segment in 2023.

6. End User: The primary end users include pharmaceutical and biotechnology companies, contract research organizations, and business process outsourcing firms, with pharmaceutical and biotechnology companies leading the market share.

7. Country: The market is segmented into the US, Canada, and Mexico, with the US dominating the market in 2023.

Key Players in the Market

Several prominent companies are active in the North American pharmacovigilance and drug safety software market, including Veeva Systems Inc., IQVIA Holdings Inc., AB Cube S.A.S., ArisGlobal LLC, Oracle Corp, Max Application, ICON Plc, Cognizant Technology Solutions Corp, Accenture Plc, Syneos Health Inc., Genpact Ltd., Laboratory Corp of America Holdings, Parexel International Corp, Qinecsa Solutions, and Clinevo Technologies. These companies are at the forefront of developing innovative solutions to enhance drug safety and pharmacovigilance practices in the region.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:
  • 3.3 Assumptions and Limitations

4. North America Pharmacovigilance and Drug Safety Software Market Landscape

  • 4.1 Overview
    • 4.1.1 Software/Service Providers:
    • 4.1.2 System Integrators:
    • 4.1.3 Regulatory Bodies:
    • 4.1.4 End-Users:
  • 4.2 List of Vendors in the Value Chain

5. North America Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

  • 5.1
  • 5.1 Market Drivers
    • 5.1.1 Rise in Incidences of Adverse Drug Reactions
    • 5.1.2 Globalization of Pharmacovigilance
    • 5.1.3 Surge in Drug Development Spending
  • 5.2 Market Restraints
    • 5.2.1 High Installation and Maintenance Costs
  • 5.3 Market Opportunities
    • 5.3.1 Integration of Software with AI, ML, and NLP
  • 5.4 Future Trends
    • 5.4.1 Cloud-Based Pharmacovigilance and Drug Safety Software:
  • 5.5 Impact of Drivers and Restraints:

6. North America Pharmacovigilance and Drug Safety Software Market - Analysis

  • 6.1 North America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021-2031
  • 6.2 North America Pharmacovigilance and Drug Safety Software Market Forecast Analysis

7. North America Pharmacovigilance and Drug Safety Software Market Analysis - by Offering

  • 7.1 Software
    • 7.1.1 Overview
    • 7.1.2 Software: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 7.2 Services
    • 7.2.1 Overview
    • 7.2.2 Services: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. North America Pharmacovigilance and Drug Safety Software Market Analysis - by Deployment

  • 8.1 Cloud
    • 8.1.1 Overview
    • 8.1.2 Cloud: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 8.2 On Premises
    • 8.2.1 Overview
    • 8.2.2 On Premises: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. North America Pharmacovigilance and Drug Safety Software Market Analysis - by Enterprise Size

  • 9.1 Large Enterprises
    • 9.1.1 Overview
    • 9.1.2 Large Enterprises: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 9.2 SMEs
    • 9.2.1 Overview
    • 9.2.2 SMEs: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

10. North America Pharmacovigilance and Drug Safety Software Market Analysis - by Form

  • 10.1 Standard
    • 10.1.1 Overview
    • 10.1.2 Standard: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 10.2 Customized
    • 10.2.1 Overview
    • 10.2.2 Customized: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

11. North America Pharmacovigilance and Drug Safety Software Market Analysis - by Functionality

  • 11.1 Signal and Risk Management
    • 11.1.1 Overview
    • 11.1.2 Signal and Risk Management: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.2 Issue Tracking and Adverse Event Tracking
    • 11.2.1 Overview
    • 11.2.2 Issue Tracking and Adverse Event Tracking: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.3 Case Management
    • 11.3.1 Overview
    • 11.3.2 Case Management: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.4 Clinical Safety Management and Clinical Trial Safety
    • 11.4.1 Overview
    • 11.4.2 Clinical Safety Management and Clinical Trial Safety: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.5 Quality and Compliance
    • 11.5.1 Overview
    • 11.5.2 Quality and Compliance: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.6 Medical Writing
    • 11.6.1 Overview
    • 11.6.2 Medical Writing: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.7 Audit Support and Training Compliance
    • 11.7.1 Overview
    • 11.7.2 Audit Support and Training Compliance: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.8 Healthcare Analytics
    • 11.8.1 Overview
    • 11.8.2 Healthcare Analytics: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.9 Others
    • 11.9.1 Overview
    • 11.9.2 Others: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

12. North America Pharmacovigilance and Drug Safety Software Market Analysis - by End User

  • 12.1 Pharmaceutical and Biotechnology Companies
    • 12.1.1 Overview
    • 12.1.2 Pharmaceutical and Biotechnology Companies: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.2 Contract Research Organizations
    • 12.2.1 Overview
    • 12.2.2 Contract Research Organizations: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.3 Business Process Outsourcing (BPO) Firms
    • 12.3.1 Overview
    • 12.3.2 Business Process Outsourcing (BPO) Firms: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.4 Others
    • 12.4.1 Overview
    • 12.4.2 Others: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

13. North America Pharmacovigilance and Drug Safety Software Market - Country Analysis

  • 13.1 North America
    • 13.1.1 North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.1.1.1 North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.1.1.2 United States: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.2.1 United States: North America Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.2.1 United States: North America Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.2.2 United States: North America Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.2.3 United States: North America Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.2.4 United States: North America Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.2.5 United States: North America Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.3 Canada: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.3.1 Canada: North America Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.3.2 Canada: North America Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.3.3 Canada: North America Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.3.4 Canada: North America Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.3.5 Canada: North America Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.3.6 Canada: North America Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.4 Mexico: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.4.1 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.4.2 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.4.3 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.4.4 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.4.5 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.4.6 Mexico: North America Pharmacovigilance and Drug Safety Software Market Share - by End User

14. Competitive Landscape

  • 14.1 Heat Map Analysis by Key Players
  • 14.2 Company Positioning and Concentration

15. Industry Landscape

  • 15.1 Overview
  • 15.2 Market Initiative
  • 15.3 Partnerships and Collaborations

16. Company Profiles

  • 16.1 ArisGlobal LLC
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Max Application
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 Oracle Corp
    • 16.3.1 Key Facts
    • 16.3.1 Business Description
    • 16.3.2 Products and Services
    • 16.3.3 Financial Overview
    • 16.3.4 SWOT Analysis
    • 16.3.5 Key Developments
  • 16.4 Veeva Systems Inc
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 IQVIA Holdings Inc
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 ICON Plc
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Cognizant Technology Solutions Corp
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Accenture Plc
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Syneos Health Inc
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments
  • 16.10 Genpact Ltd.
    • 16.10.1 Key Facts
    • 16.10.2 Business Description
    • 16.10.3 Products and Services
    • 16.10.4 Financial Overview
    • 16.10.5 SWOT Analysis
    • 16.10.6 Key Developments
  • 16.11 AB Cube S.A.S.
    • 16.11.1 Key Facts
    • 16.11.2 Business Description
    • 16.11.3 Products and Services
    • 16.11.4 Financial Overview
    • 16.11.5 SWOT Analysis
    • 16.11.6 Key Developments
  • 16.12 Laboratory Corp of America Holdings
    • 16.12.1 Key Facts
    • 16.12.2 Business Description
    • 16.12.3 Products and Services
    • 16.12.4 Financial Overview
    • 16.12.5 SWOT Analysis
    • 16.12.6 Key Developments
  • 16.13 Parexel International Corp
    • 16.13.1 Key Facts
    • 16.13.2 Business Description
    • 16.13.3 Products and Services
    • 16.13.4 Financial Overview
    • 16.13.5 SWOT Analysis
    • 16.13.6 Key Developments
  • 16.14 Qinecsa Solutions
    • 16.14.1 Key Facts
    • 16.14.2 Business Description
    • 16.14.3 Products and Services
    • 16.14.4 Financial Overview
    • 16.14.5 SWOT Analysis
    • 16.14.6 Key Developments
  • 16.15 Clinevo Technologies
    • 16.15.1 Key Facts
    • 16.15.2 Business Description
    • 16.15.3 Products and Services
    • 16.15.4 Financial Overview
    • 16.15.5 SWOT Analysis
    • 16.15.6 Key Developments

17. Appendix

  • 17.1 About Us
  • 17.2 List of Abbreviations

List Of Tables

  • Table 1. North America Pharmacovigilance and Drug Safety Software Market Segmentation
  • Table 2. List of Vendors
  • Table 3. North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Table 4. North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Offering
  • Table 5. North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Deployment
  • Table 6. North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Enterprise Size
  • Table 7. North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Form
  • Table 8. North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Functionality
  • Table 9. North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by End User
  • Table 10. North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Country
  • Table 11. United States: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 12. United States: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 13. United States: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 14. United States: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 15. United States: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 16. United States: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 17. Canada: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 18. Canada: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 19. Canada: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 20. Canada: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 21. Canada: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 22. Canada: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 23. Mexico: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 24. Mexico: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 25. Mexico: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 26. Mexico: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 27. Mexico: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 28. Mexico: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 29. List of Abbreviations

List Of Figures

  • Figure 1. North America Pharmacovigilance and Drug Safety Software Market Segmentation - Country
  • Figure 2. Ecosystem Analysis
  • Figure 3. North America Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021-2031
  • Figure 6. North America Pharmacovigilance and Drug Safety Software Market Share (%) - by Offering (2023 and 2031)
  • Figure 7. Software: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 8. Services: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 9. North America Pharmacovigilance and Drug Safety Software Market Share (%) - by Deployment (2023 and 2031)
  • Figure 10. Cloud: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 11. On Premises: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 12. North America Pharmacovigilance and Drug Safety Software Market Share (%) - by Enterprise Size (2023 and 2031)
  • Figure 13. Large Enterprises: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 14. SMEs: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 15. North America Pharmacovigilance and Drug Safety Software Market Share (%) - by Form (2023 and 2031)
  • Figure 16. Standard: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 17. Customized: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 18. North America Pharmacovigilance and Drug Safety Software Market Share (%) - by Functionality (2023 and 2031)
  • Figure 19. Signal and Risk Management: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 20. Issue Tracking and Adverse Event Tracking: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 21. Case Management: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 22. Clinical Safety Management and Clinical Trial Safety: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 23. Quality and Compliance: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 24. Medical Writing: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 25. Audit Support and Training Compliance: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 26. Healthcare Analytics: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 27. Others: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 28. North America Pharmacovigilance and Drug Safety Software Market Share (%) - by End User (2023 and 2031)
  • Figure 29. Pharmaceutical and Biotechnology Companies: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 30. Contract Research Organizations: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 31. Business Process Outsourcing (BPO) Firms: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 32. Others: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 33. North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 34. United States: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 35. Canada: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 36. Mexico: North America Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 37. Heat Map Analysis by Key Players
  • Figure 38. Company Positioning and Concentration